N/A (healthy adults)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: [1]Female aged between 40 and 60 at the time of informed consent [2] Individuals who are healthy and have no chronic physical disease including skin disease. [3] Individuals who are aware of skin deterioration such as elasticity and sagging [4]Individuals whose written informed consent has been obtained. [5]Individuals who can come to the designated venue for this study and be inspected. [6]Individuals judged appropriate for this study by a responsible doctor.
Exclusion criteria
Exclusion criteria: Individuals (who) [1]contract disease and are under treatment. [2]with skin disease,such as atopic dermatitis. [3]with strange skin conditions at measurement points. [4]used a drug to treat a disease in the past 1 month. [5]have a history of and/or contract serious diseases (eg,liver disease,kidney disease, heart disease,lung disease,blood disease). [6]have a history and/or contract digestive disease. [7]with serious anemia. [8]whose BMI are 30 or more. [9]have allergic reaction to ingredients of test foods and other foods or drugs. [10]have a habit to use functional foods and/or supplements containing collagen, specified amino acids in the past 3 months and/or are planning to use those foods during test periods. [11]have a habit to use Foods with Function Claims, functional foods and/or supplements claiming to improve skin function and/or Anti-glycation in the past 3 months and/or are planning to use those foods during test periods. [12]have a habit to use drugs claiming to improve skin function in the past 3 months. [13]are or are possibly pregnant, or are breastfeeding [14]drink more than 60g/day on average in terms of pure alcohol. [15]with psychiatric disease. [16]are smokers. [17]with possible changes of life style during test periods. [18]will develop seasonal allergy symptoms, such as pollinosis, use an anti-allergic drug. [19]neglect skin care. [20]can't avoid direct sunlight exposure, such as sunburn, during test periods. [21]had been conducted an operation or beauty treatment on the test spot in the past 6 months. [22]are participating and/or had participated in other clinical studies within the last 3 months. [23]are judged as not appropriate to this study by a responsible doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fluorescent AGEs (AF), Skin viscoelasticity,Transepidermal water loss,Moisture of the skin surface,VISIA score,Skin color quantification,Observation for skin condition by dermatologists, Blood AGEs(Pentosidine) | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood glucose level, Glycated albumin,HbA1c, Anti-Aging QOL Common Questionnaire | — |
Countries
Japan
Contacts
TES Holdings Co., Ltd. Department of Clinical Trial